Teri Schreiner, MD
Neurology with Special Qualifications in Child Neurology · Aurora, CONPI 1932255601
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (58.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Roche Products Limited accounts for 79.9% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2022 at $1,500 and has fallen 85.4% since, to $219 in 2025.
Across 12 payments — averaging $271.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Roche Products Limited$3K
- Sanofi US Services Inc.$400
- TG Therapeutics, Inc.$219
- Bristol Myers Squibb$36
Across 113 payments — averaging $9843.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Hoffmann-la Roche Limited$609K
- Genentech, Inc.$354K
- Biogen$72K
- Adamas Pharmaceuticals, Inc.$70K
- F. Hoffmann-la Roche AG$6K
- Roche Products Limited$1K
What the payments were for
- Consulting fees$1,90058%
- Speaking & faculty fees$3009%
- Travel & lodging$72522%
- Food & beverage$33410%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Roche Products Limited | 6 | $2,604 |
| Sanofi US Services Inc. | 2 | $400 |
| TG Therapeutics, Inc. | 2 | $219 |
| Bristol Myers Squibb | 2 | $36 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,259 in reported general payments places this provider in the 85th percentile of 41 neurology with special qualifications in child neurology providers in Colorado.
See all neurology with special qualifications in child neurology providers in Colorado →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 26 | $42,124 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 13 | $419 |
| Sertraline Hcl | 12 | $220 |
Paid to pharmacies, not to this prescriber.
Other neurology with special qualifications in child neurology in Aurora
- Julie ParsonsAurora$178K
- Michele YangAurora$15K
- Timothy BenkeAurora$9K
- Ryan KammeyerAurora$4K
- Marcy YonkerAurora$3K
- Jessica LitwinAurora$2K
- Jennifer ArmstrongAurora$2K
- Abigail CollinsAurora$2K
- Jennifer JaskiewiczAurora$937
- Benjamin RossAurora$803
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.